Lymphocyte-activating polypeptides

Details Lymphocyte-activating polypeptides Lymphocyte-activating polypeptides

1986-01-09

1987-07-28

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 15, 514 16, 514 17, 514 18, 530327, 530328, 530329, 530330, 530388, A61K 3702, C07K 510, C07K 706

Patent

active

046832211

ABSTRACT:
A lymphocyte-activating polypeptide, a composition containing the polypeptide and a method for using the composition are disclosed. The polypeptide contains a sequence of 4 to about 11 residues and corresponds in sequence to the formula:

REFERENCES:
patent: 4415493 (1983-11-01), Weigle et al.
patent: 4579840 (1986-04-01), Hahn
Morgan et al., Proc. Natl. Acad. Sci. USA, vol. 79, pp. 5388-5391, Sep. 1982.
Reitcliffe et al., Biological Abstract, vol. 74, No. 83493, 1982.

Affiliated with

Also associated with

Rating

Lymphocyte-activating polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lymphocyte-activating polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lymphocyte-activating polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2034943